ReviewCancer management and research2016

Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer.

William J GradisharPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.